← All organizations

Myeloproliferative Disorders Research Consoritum

Myeloproliferative Disorders Research Consoritum

Academic/Hospital

Also known as: Myeloproliferative Disorders-Research Consortium

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2014

Timeline

2000s

Jan 1, 2006
Myeloproliferative Disorders Research Consoritum— Founded

Drugs by trial phase (11 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT02076191CollaboratorPhase 1/Phase 2Feb 1, 2014
NCT01790295CollaboratorPhase 2Feb 1, 2013
NCT01259856CollaboratorPhase 3Sep 1, 2011
NCT01259817Overall official - principal investigatorPhase 2Sep 1, 2011
NCT01259817CollaboratorPhase 2Sep 1, 2011
NCT00940784CollaboratorPhase 2Jun 1, 2009
NCT00668421CollaboratorPhase 1/Phase 2Apr 1, 2008
NCT00667277Overall official - principal investigatorPhase 2Mar 1, 2008
NCT00667277CollaboratorPhase 2Mar 1, 2008
NCT00572897Study chairPhase 2Aug 1, 2007
NCT00572897CollaboratorPhase 2Aug 1, 2007

Details

Founded: Chicago, IL, US Jan 1, 2006
Last known activity: Feb 1, 2014